Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Determine the Range of Tissue Frataxin Concentrations and Other Potential Biomarkers for Friedreich's Ataxia in Normal Healthy Volunteers

NCT05028764 is registered in ClinicalTrials.gov with Larimar Therapeutics, Inc. as lead sponsor.

NCT NCT05028764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05028764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Determine the Range of Tissue Frataxin Concentrations and Other Potential Biomarkers for Friedreich's Ataxia in Normal Healthy Volunteers
Lead sponsor
Larimar Therapeutics, Inc.
Phase
Observational
Overall status
Completed
Start date
August 4, 2021
Completion date
February 4, 2022
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

friedreich ataxia, healthy volunteers